Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
IHC - Frozen, Western blot, ELISA (applications tested for the base form of this product only)
Mycoplasma pneumoniae (tested or 100% immunogen sequence identity)
IHC - Frozen (1:20 - 1:200)
Western blot (1:20 - 1:200)
ELISA (1:200 - 1:1000)
(applications tested for the base form of this product only)
Specificity and Use
Recognizes M. pneumoniae, a bacterium which is distinguished phenotypically from other bacteria by lacking a peptidoglycan cell wall. M. pneumoniae is exclusively a human pathogen, and primarily attaches to mucosa in the upper and lower respiratory tract. It is transmitted by respiratory droplets, and infection can cause bronchial asthma, bronchitis and pneumonia. Central nervous system (CNS) manifestations are the most frequent extrapulmonary complications, and include encephalitis, aseptic meningitis, cerebellar ataxia, and myelitis. Has not been cross absorbed and may react with related microorganisms.
The applications listed have been tested for the base form of this product. Alternate forms, such as conjugated, azide-free, or ready-to-use, have not been tested.